Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A Biotech Breakthrough Means Big Gains for These 2 Stocks
A Biotech Breakthrough Means Big Gains for These 2 Stocks
A Biotech Breakthrough Means Big Gains for These 2 Stocks
Submitted by
admin
on September 28, 2022 - 11:02am
Source:
Motley Fool
News Tags:
Eli Lilly
Biogen
Alzheimer's disease
lecanemab
donanemab
Headline:
A Biotech Breakthrough Means Big Gains for These 2 Stocks
snippet:
Stock markets were mixed Wednesday morning as investors wrestled with ongoing uncertainty.
Biogen shares soared after the company announced positive trial results for its latest Alzheimer's treatment.
Eli Lilly rose in sympathy as it, too, has a candidate treatment for the disease in its pipeline.
Do Not Allow Advertisers to Use My Personal information